Endeavor Biomedicines Stock
Endeavor Biomedicines is a clinical-stage biotechnology company developing precision medicines targeting drivers of fibrosis, oncology, and other diseases. By leveraging a deep understanding of disease biology, the company focuses on creating innovative therapies that address significant unmet medical needs and improve patient outcomes.
Founded: 2019
For more Endeavor Biomedicines stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| John Hood Co-Founder and Chief Executive Officer |
| Miguel de los Rios Co-Founder and Chief Scientific Officer |
| Enoch Kariuki President |
| Vishaal Turakhia Chief Financial Officer |
